Grace in South Haven, Michigan

Opened in 1976, Grace’s South Haven, Michigan site is one of two plants in our Fine Chemical Manufacturing Services (FCMS) business. Grace acquired the FCMS business from Albemarle Corporation in 2021. The other site in the network is based in Tyrone, Pennsylvania.

Our South Haven site is a full-service cGMP custom manufacturing facility serving the pharmaceutical drug substance market for over 40 years. South Haven contains everything required to develop APIs to commercialization and manufactures high-quality ingredients that are used in a wide range of therapeutic areas, including oncology, diabetes, cardiovascular and antiviral. High-throughput parallel reactor systems facilitate FDA Q8 compliance as CDMO.

Alongside substantial R&D capacity and resources for new product development, there is a cGMP kilo lab and pilot plant to support scale-up. On-site analytical teams at this FDA-regulated facility support method development.

South Haven Info

• Approximately 200 employees
• Established in 1976
• Acquired in 2021
• Primary Activities: Manufacturing and Pharmaceutical process R&D
• Products: Full-service cGMP custom manufacturing facility, generic and custom Active Pharmaceutical Ingredients (APIs), Other potential cGMP products
• Applications: Pharmaceuticals; Nutraceuticals
• Certifications: Michigan Voluntary Protection Program (MVPP); ACC Responsible Care Management System; GMP (21 CFR part 211 cGMP) - FDA registered facility for API manufacture